Cancer-related lymphedema risk factors, diagnosis, treatment, and impact: a review.
Identifieur interne : 004470 ( Main/Exploration ); précédent : 004469; suivant : 004471Cancer-related lymphedema risk factors, diagnosis, treatment, and impact: a review.
Auteurs : Electra D. Paskett [États-Unis] ; Julie A. Dean ; Jill M. Oliveri ; J Phil HarropSource :
- Journal of clinical oncology : official journal of the American Society of Clinical Oncology [ 1527-7755 ] ; 2012.
Descripteurs français
- KwdFr :
- MESH :
- diagnostic : Lymphoedème.
- étiologie : Lymphoedème.
- Biopsie de noeud lymphatique sentinelle, Exercice physique, Facteurs de risque, Humains, Lymphoedème, Surpoids, Survivants, Tumeurs.
English descriptors
- KwdEn :
- MESH :
- complications : Neoplasms.
- diagnosis : Lymphedema.
- etiology : Lymphedema.
- therapy : Lymphedema, Neoplasms.
- Exercise, Humans, Overweight, Risk Factors, Sentinel Lymph Node Biopsy, Survivors.
Abstract
PURPOSE Cancer-related lymphedema (LE) is an incurable condition associated with lymph-involved cancer treatments and is an increasing health, quality of life (QOL), and cost burden on a growing cancer survivor population. This review examines the evidence for causes, risk, prevention, diagnosis, treatment, and impact of this largely unexamined survivorship concern. METHODS PubMed and Medline were searched for cancer-related LE literature published since 1990 in English. The resulting references (N = 726) were evaluated for strength of design, methods, sample size, and recent publication and sorted into categories (ie, causes/prevention, diagnosis, treatment, and QOL). Sixty studies were included. Results Exercise and physical activity and sentinel lymph node biopsy reduce risk, and overweight and obesity increase risk. Evidence that physiotherapy reduces risk and that lymph node status and number of malignant nodes increase risk is less strong. Perometry and bioimpedence emerged as attractive diagnostic technologies, replacing the use of water displacement in clinical practice. Swelling can also be assessed by measuring arm circumference and relying on self-report. Symptoms can be managed, not cured, with complex physical therapy, low-level laser therapy, pharmacotherapy, and surgery. Sequelae of LE negatively affect physical and mental QOL and range in severity. However, the majority of reviewed studies involved patients with breast cancer; therefore, results may not be applicable to all cancers. CONCLUSION Research into causes, prevention, and effect on QOL of LE and information on LE in cancers other than breast is needed. Consensus on definitions and measurement, increased patient and provider awareness of signs and symptoms, and proper and prompt treatment/access, including psychosocial support, are needed to better understand, prevent, and treat LE.
DOI: 10.1200/JCO.2012.41.8574
PubMed: 23008299
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: 001F47
- to stream PubMed, to step Curation: 001F47
- to stream PubMed, to step Checkpoint: 001F47
- to stream Ncbi, to step Merge: 005155
- to stream Ncbi, to step Curation: 005155
- to stream Ncbi, to step Checkpoint: 005155
- to stream Main, to step Merge: 004491
- to stream Main, to step Curation: 004470
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Cancer-related lymphedema risk factors, diagnosis, treatment, and impact: a review.</title><author><name sortKey="Paskett, Electra D" sort="Paskett, Electra D" uniqKey="Paskett E" first="Electra D" last="Paskett">Electra D. Paskett</name><affiliation wicri:level="2"><nlm:affiliation>The Ohio State University, Columbus, OH 43201, USA. electra.paskett@osumc.edu</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>The Ohio State University, Columbus, OH 43201</wicri:regionArea><placeName><region type="state">Ohio</region></placeName></affiliation></author><author><name sortKey="Dean, Julie A" sort="Dean, Julie A" uniqKey="Dean J" first="Julie A" last="Dean">Julie A. Dean</name></author><author><name sortKey="Oliveri, Jill M" sort="Oliveri, Jill M" uniqKey="Oliveri J" first="Jill M" last="Oliveri">Jill M. Oliveri</name></author><author><name sortKey="Harrop, J Phil" sort="Harrop, J Phil" uniqKey="Harrop J" first="J Phil" last="Harrop">J Phil Harrop</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2012">2012</date><idno type="RBID">pubmed:23008299</idno><idno type="pmid">23008299</idno><idno type="doi">10.1200/JCO.2012.41.8574</idno><idno type="wicri:Area/PubMed/Corpus">001F47</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">001F47</idno><idno type="wicri:Area/PubMed/Curation">001F47</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">001F47</idno><idno type="wicri:Area/PubMed/Checkpoint">001F47</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">001F47</idno><idno type="wicri:Area/Ncbi/Merge">005155</idno><idno type="wicri:Area/Ncbi/Curation">005155</idno><idno type="wicri:Area/Ncbi/Checkpoint">005155</idno><idno type="wicri:Area/Main/Merge">004491</idno><idno type="wicri:Area/Main/Curation">004470</idno><idno type="wicri:Area/Main/Exploration">004470</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Cancer-related lymphedema risk factors, diagnosis, treatment, and impact: a review.</title><author><name sortKey="Paskett, Electra D" sort="Paskett, Electra D" uniqKey="Paskett E" first="Electra D" last="Paskett">Electra D. Paskett</name><affiliation wicri:level="2"><nlm:affiliation>The Ohio State University, Columbus, OH 43201, USA. electra.paskett@osumc.edu</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>The Ohio State University, Columbus, OH 43201</wicri:regionArea><placeName><region type="state">Ohio</region></placeName></affiliation></author><author><name sortKey="Dean, Julie A" sort="Dean, Julie A" uniqKey="Dean J" first="Julie A" last="Dean">Julie A. Dean</name></author><author><name sortKey="Oliveri, Jill M" sort="Oliveri, Jill M" uniqKey="Oliveri J" first="Jill M" last="Oliveri">Jill M. Oliveri</name></author><author><name sortKey="Harrop, J Phil" sort="Harrop, J Phil" uniqKey="Harrop J" first="J Phil" last="Harrop">J Phil Harrop</name></author></analytic><series><title level="j">Journal of clinical oncology : official journal of the American Society of Clinical Oncology</title><idno type="eISSN">1527-7755</idno><imprint><date when="2012" type="published">2012</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Exercise</term><term>Humans</term><term>Lymphedema (diagnosis)</term><term>Lymphedema (etiology)</term><term>Lymphedema (therapy)</term><term>Neoplasms (complications)</term><term>Neoplasms (therapy)</term><term>Overweight</term><term>Risk Factors</term><term>Sentinel Lymph Node Biopsy</term><term>Survivors</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Biopsie de noeud lymphatique sentinelle</term><term>Exercice physique</term><term>Facteurs de risque</term><term>Humains</term><term>Lymphoedème ()</term><term>Lymphoedème (diagnostic)</term><term>Lymphoedème (étiologie)</term><term>Surpoids</term><term>Survivants</term><term>Tumeurs ()</term></keywords><keywords scheme="MESH" qualifier="complications" xml:lang="en"><term>Neoplasms</term></keywords><keywords scheme="MESH" qualifier="diagnosis" xml:lang="en"><term>Lymphedema</term></keywords><keywords scheme="MESH" qualifier="diagnostic" xml:lang="fr"><term>Lymphoedème</term></keywords><keywords scheme="MESH" qualifier="etiology" xml:lang="en"><term>Lymphedema</term></keywords><keywords scheme="MESH" qualifier="therapy" xml:lang="en"><term>Lymphedema</term><term>Neoplasms</term></keywords><keywords scheme="MESH" qualifier="étiologie" xml:lang="fr"><term>Lymphoedème</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Exercise</term><term>Humans</term><term>Overweight</term><term>Risk Factors</term><term>Sentinel Lymph Node Biopsy</term><term>Survivors</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Biopsie de noeud lymphatique sentinelle</term><term>Exercice physique</term><term>Facteurs de risque</term><term>Humains</term><term>Lymphoedème</term><term>Surpoids</term><term>Survivants</term><term>Tumeurs</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">PURPOSE Cancer-related lymphedema (LE) is an incurable condition associated with lymph-involved cancer treatments and is an increasing health, quality of life (QOL), and cost burden on a growing cancer survivor population. This review examines the evidence for causes, risk, prevention, diagnosis, treatment, and impact of this largely unexamined survivorship concern. METHODS PubMed and Medline were searched for cancer-related LE literature published since 1990 in English. The resulting references (N = 726) were evaluated for strength of design, methods, sample size, and recent publication and sorted into categories (ie, causes/prevention, diagnosis, treatment, and QOL). Sixty studies were included. Results Exercise and physical activity and sentinel lymph node biopsy reduce risk, and overweight and obesity increase risk. Evidence that physiotherapy reduces risk and that lymph node status and number of malignant nodes increase risk is less strong. Perometry and bioimpedence emerged as attractive diagnostic technologies, replacing the use of water displacement in clinical practice. Swelling can also be assessed by measuring arm circumference and relying on self-report. Symptoms can be managed, not cured, with complex physical therapy, low-level laser therapy, pharmacotherapy, and surgery. Sequelae of LE negatively affect physical and mental QOL and range in severity. However, the majority of reviewed studies involved patients with breast cancer; therefore, results may not be applicable to all cancers. CONCLUSION Research into causes, prevention, and effect on QOL of LE and information on LE in cancers other than breast is needed. Consensus on definitions and measurement, increased patient and provider awareness of signs and symptoms, and proper and prompt treatment/access, including psychosocial support, are needed to better understand, prevent, and treat LE.</div></front></TEI><affiliations><list><country><li>États-Unis</li></country><region><li>Ohio</li></region></list><tree><noCountry><name sortKey="Dean, Julie A" sort="Dean, Julie A" uniqKey="Dean J" first="Julie A" last="Dean">Julie A. Dean</name><name sortKey="Harrop, J Phil" sort="Harrop, J Phil" uniqKey="Harrop J" first="J Phil" last="Harrop">J Phil Harrop</name><name sortKey="Oliveri, Jill M" sort="Oliveri, Jill M" uniqKey="Oliveri J" first="Jill M" last="Oliveri">Jill M. Oliveri</name></noCountry><country name="États-Unis"><region name="Ohio"><name sortKey="Paskett, Electra D" sort="Paskett, Electra D" uniqKey="Paskett E" first="Electra D" last="Paskett">Electra D. Paskett</name></region></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 004470 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 004470 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= LymphedemaV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= pubmed:23008299
|texte= Cancer-related lymphedema risk factors, diagnosis, treatment, and impact: a review.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:23008299" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \
| NlmPubMed2Wicri -a LymphedemaV1
| This area was generated with Dilib version V0.6.31. |  |